Posted by TheOutsider on January 23, 2005, at 11:55:14
In reply to Re: CCK-B antagonists » TheOutsider, posted by Michael Bell on January 23, 2005, at 9:58:39
> I believe these are the CCK-B antagonists in development. Some may be derivatives of the others listed. I think that GW150013 is in the Phase II clinical trial period and is being developed by GlaxoSmithKline. CR 2945 may also be in Phase I or Phase II. Some of the others may have been discontinued.
>
> L-365,260
> CR 2945
> PD134308
> PD135158
> L-736,380
> GW150013Thanks for the Info Michael
Its unfortunate that the most advanced are only in phase II clinical trials, that must mean their years away from release.
That is assuming of course that they ever do get released!
poster:TheOutsider
thread:444453
URL: http://www.dr-bob.org/babble/20050119/msgs/446205.html